查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589603

藥物釋放型支架市場：藥物塗層，按應用分類 - 全球預測 2025-2030

Drug Eluting Stent Market by Drug Coating (Polymer Free Coatings, Polymer-Based Coatings), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

藥物釋放型支架市場2023年估值為72.7億美元，預計2024年將達到80.5億美元，複合年成長率為10.84%，預計到2030年將達到149.4億美元。

藥物釋放型支架 (DES) 是介入性心臟病學中用於預防冠狀動脈粥狀硬化阻塞復發的專用冠狀動脈支架。這些支架上塗有藥物，緩慢釋放的藥物抑制細胞增殖，有效維持血管通暢性。對 DES 的需求源於需要透過最大限度地減少血管再阻塞（一種與裸金屬支架相關的常見併發症）來改善經經皮冠狀動脈介入治療的結果。 DES 廣泛應用於心臟病學，也延伸到冠狀動脈疾病的治療，醫院和心臟中心是主要的最終用戶。 DES 市場的主要成長要素包括全球心血管疾病盛行率上升、人口老化以及提高支架有效性和生物相容性的技術進步。此外，正在進行的新型藥物配方和生物可吸收支架的研究也帶來了有希望的成長機會。為了保持競爭力，公司可以探索策略夥伴關係並投資研究以開發下一代支架。然而，市場開拓面臨嚴格的監管要求、DES 的高成本和報銷問題等挑戰，阻礙了採用，特別是在新興經濟體。另一個潛在的限制是併發症的發生，例如支架晚期血栓症和需要延長雙聯抗血小板治療。為了抓住新的機遇，公司應該專注於藥物包衣的創新，推廣生物分解性的選擇，並透過發展醫療基礎設施來拓展開拓的市場。在產品開發的積極研發以及旨在擴大市場佔有率的頻繁併購的推動下，市場競爭仍然激烈。成功的關鍵在於平衡創新和成本效益、回應監管環境並有效解決病人安全問題。透過策略性地瞄準新興市場並投資最尖端科技，公司可以在藥物釋放型支架的動態格局中充分利用巨大的成長潛力。

主要市場統計
基準年[2023] 72.7億美元
預測年份 [2024] 80.5億美元
預測年份 [2030] 149.4億美元
複合年成長率（%） 10.84%

市場動態：快速發展的藥物釋放型支架市場的關鍵市場洞察

藥物釋放型支架市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 由於動脈疾病的風險增加，老年人口不斷增加
    • 動脈硬化盛行率上升
    • 糖尿病和心臟麻痹等慢性病盛行率增加
  • 市場限制因素
    • 與藥物釋放型支架相關的風險
  • 市場機會
    • 透過引入生物可吸收支架支持微創手術
    • 改善新興國家的醫療基礎設施
  • 市場挑戰
    • 產品召回問題

波特的五力：駕馭藥物釋放型支架市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物釋放型支架市場的外部影響

外部宏觀環境因素對藥物釋放型支架市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥物釋放型支架市場的競爭格局

藥物釋放型支架市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣藥物釋放型支架市場供應商績效評估

FPNV定位矩陣是評估藥物釋放型支架市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製藥物釋放型支架市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，藥物釋放型支架市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著人口老化的加劇，動脈疾病的風險也增加。
      • 動脈硬化盛行率上升
      • 糖尿病和心臟麻痹等慢性疾病增加
    • 抑制因素
      • 與藥物釋放型支架相關的風險
    • 機會
      • 生物可吸收支架的引入使微創手術成為可能
      • 改善新興國家的醫療基礎設施
    • 任務
      • 產品召回問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥物釋放型支架市場藥物塗層

  • 無聚合物塗層
    • 微孔表面
    • 微結構表面
    • 奈米多孔表面
    • 開槽管狀表面
  • 聚合物基塗料
    • 生物分解性聚合物
    • 非生物分解的聚合物

第7章藥物釋放型支架市場：依應用分類

  • 冠狀動脈疾病
  • 周邊動脈疾病

第8章美洲藥物釋放型支架市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太藥物釋放型支架市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲藥物釋放型支架市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Alvimedica
  • Arkray, Inc.
  • B. Braun
  • Biosensors International Group, Ltd.
  • Biotronik
  • Boston Scientific Corporation
  • Cook Medical LLC
  • HEXACATH
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical LLC
  • Shandong JW Medical Systems LTD.
  • Terumo Corporation
Product Code: MRR-807A20B5CCC6

The Drug Eluting Stent Market was valued at USD 7.27 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 10.84%, to USD 14.94 billion by 2030.

Drug-eluting stents (DES) are specialized coronary stents used in interventional cardiology to prevent the recurrence of arteriosclerotic blockages in coronary arteries. These stents are coated with medication that is gradually released to inhibit cell proliferation, thus maintaining vessel patency effectively. The necessity for DES arises from the need to improve outcomes of percutaneous coronary interventions by minimizing restenosis, a common complication associated with bare-metal stents. Widely utilized in cardiology, their applications extend to treating coronary artery disease, and hospitals and specialized cardiac centers represent the primary end-users. Key growth factors for the DES market include the rising prevalence of cardiovascular diseases globally, an aging population, and technological advancements that enhance stent efficacy and biocompatibility. Furthermore, ongoing research into novel drug formulations and bioresorbable stents offers promising growth opportunities. Companies could explore strategic partnerships and invest in research to develop next-generation stents to remain competitive. However, market growth faces challenges such as stringent regulatory requirements, high costs of DES, and reimbursement issues that could hinder adoption, especially in developing economies. Potential limitations also include complications like late stent thrombosis, necessitating extended dual antiplatelet therapy. To capture emerging opportunities, businesses should focus on innovation in drug coatings, promoting biodegradable options, and expanding in underserved markets with growing healthcare infrastructure. The market remains highly competitive, underscored by aggressive R&D in product development and frequent mergers and acquisitions aimed at expanding market share. Success relies on the ability to balance innovation with cost-effectiveness, navigating regulatory landscapes, and effectively addressing patient safety concerns. By strategically targeting emerging markets and investing in cutting-edge technologies, companies can leverage significant growth potential within the dynamic landscape of drug-eluting stents.

KEY MARKET STATISTICS
Base Year [2023] USD 7.27 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 14.94 billion
CAGR (%) 10.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Stent Market

The Drug Eluting Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population along with growing high risk of developing arterial diseases
    • Rising prevalence rate of atherosclerosis
    • Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
  • Market Restraints
    • Risks associated with drug eluting stent
  • Market Opportunities
    • Introduction of bio resorbable stents support minimally invasive surgeries
    • Improving healthcare infrastructure in emerging economies
  • Market Challenges
    • Issues related to product recall

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Stent Market

A detailed market share analysis in the Drug Eluting Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Eluting Stent Market

A strategic analysis of the Drug Eluting Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alvimedica, Arkray, Inc., B. Braun, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical LLC, HEXACATH, KYOTO MEDICAL PLANNING Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical LLC, Shandong JW Medical Systems LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Coating, market is studied across Polymer Free Coatings and Polymer-Based Coatings. The Polymer Free Coatings is further studied across Micro Porous Surface, Micro Structured Surface, Nanoporous Surface, and Slotted Tubular Surface. The Polymer-Based Coatings is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.
  • Based on Application, market is studied across Coronary Artery Disease and Peripheral Artery Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population along with growing high risk of developing arterial diseases
      • 5.1.1.2. Rising prevalence rate of atherosclerosis
      • 5.1.1.3. Increasing prevalence of chronic diseases, such as diabetes and cardiac arrest
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with drug eluting stent
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of bio resorbable stents support minimally invasive surgeries
      • 5.1.3.2. Improving healthcare infrastructure in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Eluting Stent Market, by Drug Coating

  • 6.1. Introduction
  • 6.2. Polymer Free Coatings
    • 6.2.1. Micro Porous Surface
    • 6.2.2. Micro Structured Surface
    • 6.2.3. Nanoporous Surface
    • 6.2.4. Slotted Tubular Surface
  • 6.3. Polymer-Based Coatings
    • 6.3.1. Biodegradable Polymers
    • 6.3.2. Non-Biodegradable Polymers

7. Drug Eluting Stent Market, by Application

  • 7.1. Introduction
  • 7.2. Coronary Artery Disease
  • 7.3. Peripheral Artery Disease

8. Americas Drug Eluting Stent Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Drug Eluting Stent Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Drug Eluting Stent Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alvimedica
  • 3. Arkray, Inc.
  • 4. B. Braun
  • 5. Biosensors International Group, Ltd.
  • 6. Biotronik
  • 7. Boston Scientific Corporation
  • 8. Cook Medical LLC
  • 9. HEXACATH
  • 10. KYOTO MEDICAL PLANNING Co., Ltd.
  • 11. Lepu Medical Technology (Beijing) Co., Ltd.
  • 12. Medtronic PLC
  • 13. Meril Life Sciences Pvt. Ltd.
  • 14. MicroPort Scientific Corporation
  • 15. REVA Medical LLC
  • 16. Shandong JW Medical Systems LTD.
  • 17. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. DRUG ELUTING STENT MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG ELUTING STENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG ELUTING STENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG ELUTING STENT MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MICRO POROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MICRO STRUCTURED SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NANOPOROUS SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY SLOTTED TUBULAR SURFACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE COATINGS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER-BASED COATINGS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2023